Business Description
Restart Life Sciences Corp
NAICS : 541714
SIC : 3741
ISIN : CA53069P1018
Compare
Compare
Traded in other countries / regions
HEAL.X.CanadaNMLSF.USAHN3.Germany IPO Date
2008-08-19Description
Restart Life Sciences Corp is a Canadian life sciences company dedicated to addressing today's health challenges with wellness solutions. It is focus is on creating health foods that address the needs of this community. Its Flagship developments includes Autism Spectrum, Health-Related Foods, Psilocybin Clinical Trial for Fragile X Syndrome, Orphan Drug Designation (FDA and EMA).
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.18 | |||||
| Equity-to-Asset | -2.2 | |||||
| Debt-to-Equity | -0.1 | |||||
| Debt-to-EBITDA | -0.17 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | N/A/9 | |||||
| Altman Z-Score | -312.05 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 27.8 | |||||
| 3-Year EPS without NRI Growth Rate | 26.9 | |||||
| 3-Year FCF Growth Rate | 27.1 | |||||
| 3-Year Book Growth Rate | -89.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 21.64 | |||||
| 9-Day RSI | 30.28 | |||||
| 14-Day RSI | 38.41 | |||||
| 6-1 Month Momentum % | -30 | |||||
| 12-1 Month Momentum % | 600 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.3 | |||||
| Quick Ratio | 0.3 | |||||
| Cash Ratio | 0.29 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -65.3 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | Neg. Equity | |||||
| ROA % | 233.16 | |||||
| ROIC % | -645.74 | |||||
| ROC (Joel Greenblatt) % | -3348.84 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 2.92 | |||||
| EV-to-EBIT | -2.47 | |||||
| EV-to-EBITDA | -2.48 | |||||
| EV-to-FCF | -17.83 | |||||
| Earnings Yield (Greenblatt) % | -40.48 | |||||
| FCF Yield % | -5.55 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Restart Life Sciences Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | 0.008 | ||
| Beta | 10.59 | ||
| Volatility % | 1087.57 | ||
| 14-Day RSI | 38.41 | ||
| 14-Day ATR (€) | 0.001416 | ||
| 20-Day SMA (€) | 0.0166 | ||
| 12-1 Month Momentum % | 600 | ||
| 52-Week Range (€) | 0.0001 - 0.032 | ||
| Shares Outstanding (Mil) | 36.02 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Restart Life Sciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Restart Life Sciences Corp Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Restart Life Sciences Corp Frequently Asked Questions
What is Restart Life Sciences Corp(FRA:HN3)'s stock price today?
The current price of FRA:HN3 is €0.01. The 52 week high of FRA:HN3 is €0.03 and 52 week low is €0.00.
When is next earnings date of Restart Life Sciences Corp(FRA:HN3)?
The next earnings date of Restart Life Sciences Corp(FRA:HN3) is .
Does Restart Life Sciences Corp(FRA:HN3) pay dividends? If so, how much?
Restart Life Sciences Corp(FRA:HN3) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers